Financials
- Market Capitalization 548.93 M
- Employee 1 315
- Founded 2011
- CEO Ming Hsieh
- Website www.fulgentgenetics.com
- Headquarter Delaware, United States
- FIGI BBG00DR7LTG2
- Industry Diagnóstico y pruebas
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-13.36
Relación precio/flujo de caja
2.51
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2432 | CSTL Castle Biosciences, Inc. - Common stock | 34.26 USD | +0.53% | +6.60% | +43.17% | +39.18% | 1.05 B USD | ||
| 2515 | ACRS Aclaris Therapeutics, Inc. - Common Stock | 6.16 USD | -0.48% | -3.14% | +15.36% | +232.97% | 906.75 M USD | ||
| 3007 | PRE Prenetics Global Limited - Class A Ordinary Share | 26.25 USD | +1.82% | +50.86% | +43.84% | +248.14% | 442.94 M USD | ||
| 3316 | MYGN Myriad Genetics, Inc. - Common Stock | 3.18 USD | +1.92% | -1.24% | -40.34% | -61.55% | 304.17 M USD |